SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001136261-10-000104
Filing Date
2010-05-05
Accepted
2010-05-05 17:10:21
Documents
9
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q body10q.htm 10-Q 407604
3 CEO 302 CETIFICATE exh31-1.htm EX-31.1 6636
4 CFO 302 CETIFICATE exh31-2.htm EX-31.2 6660
5 906 CERTIFICATE exh32.htm EX-32 2914
6 10-Q form10q.pdf 10-Q 391338
7 CEO 302 CETIFICATE exhibit31-1.pdf EX-31.1 106206
8 CFO 302 CETIFICATE exhibit31-2.pdf EX-31.2 104664
9 906 CERTIFICATE exhibit32.pdf EX-32 84547
10 LOGO newlogo.jpg GRAPHIC 111746
  Complete submission text file 0001136261-10-000104.txt   1526148
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23272 | Film No.: 10802813
SIC: 2836 Biological Products, (No Diagnostic Substances)